No Data
No Data
Menovo Pharmaceutical Unit Gets Registration Certificate for Glucosamine Sulfate Capsules
Ningbo Menovo Pharmaceutical (SHA:603538) unit Ningbo Menovo Tiankang Pharmaceutical obtained a drug registration certificate for glucosamine sulfate capsules from Chinese drug regulator National Medi
Ningbo Menovo Pharmaceutical (603538.SH): Wholly-owned subsidiary obtained pharmaceutical registration certificate for ammonium sulfate glucosamine capsules.
Ningbo Menovo Pharmaceutical, a wholly-owned subsidiary of Menovo Pharmaceutical (603538.SH), announced on June 25th that it has recently received the Drug Registration Certificate for Glucosamine Sulfate Capsules from the National Medical Products Administration. The drug is used for the treatment of primary and secondary osteoarthritis.
Express News | Minovar: Wholly-owned subsidiary dapagliflozin API passed CDE technical review
Express News | Minovar: The holding subsidiary's APIs passed the CDE technical review
China Approves Menovo Pharma's Type 2 Diabetes Drug
China approved Ningbo Menovo Pharmaceutical (SHA:603538) unit Ningbo Minohua Tiankang Pharmaceutical's sitagliptin metformin tablets for type 2 diabetes, according to a Thursday filing with the Shangh
Express News | Menovar: Wholly-owned subsidiary obtains drug registration certificate for sitagliptin metformin tablets
No Data